Naoto Okada

Yamaguchi University Hospital — Japan

Medicine · Health Sciences

20h-index1.4kcitations105works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antimicrobial Resistance in Staphylococcus(9), Antibiotics Pharmacokinetics and Efficacy(9), Cancer Treatment and Pharmacology(9), Multiple Myeloma Research and Treatments(8), Cancer Immunotherapy and Biomarkers(7)

Publications105 total

Clinical Feasibility of Nomogram-Based Vancomycin Dosing Strategy: A Retrospective Study
Biological and Pharmaceutical Bulletin·2026Open Access
Risk Factor of Persistent Hypotension Associated with 5-Aminolevulinic Acid: A Single-Institution Retrospective Study
Biological and Pharmaceutical Bulletin·2026Open Access
Impact of immunotherapy on survival and treatment patterns of patients with extensive-stage small cell lung cancer: a study using a Japanese nationwide database
Future Oncology·2026
MicroRNA-based discrimination of hepatotoxic and non-hepatotoxic drugs using a humanized liver mouse model
Toxicology Letters·2026
Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases
Frontiers in Pharmacology·2025Open Access
Novel noninvasive parameters for diagnosis of liver involvement in patients with systemic AL amyloidosis
International Journal of Hematology·2025Open Access
Impact of coronavirus disease on the incidence rate of methicillin-resistant Staphylococcus aureus among hospitalized patients with lung cancer: a nationwide retrospective cohort study in Japan
Journal of Pharmaceutical Health Care and Sciences·2025Open Access
Risk Factors for Lower Adherence to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer: A Nationwide Retrospective Cohort Study in Japan
Oncology·2025
Effectiveness of Statins for Oxaliplatin‐Induced Peripheral Neuropathy: A Multicenter Retrospective Observational Study
Clinical and Translational Science·2025Open Access
Changes in the trend and quality of adverse drug reaction reports in the Japanese Adverse Drug Event Report database and the impact of COVID-19-related reports
International Journal of Pharmacy Practice·2025Open Access
Diagnostic Potential of Shear Wave Elastography for Liver Involvement in AL Amyloidosis
Clinical Lymphoma Myeloma & Leukemia·2025
P04-09 Changes in miRNA levels as biomarkers for drug-induced liver injury in human plasma
Toxicology Letters·2025Open Access
Characterization of Lachnoanaerobaculum sanguinis sp. nov., isolated from a blood culture of an acute myeloid leukemia patient with chemotherapy-related bacteremia
Anaerobe·2025· 1 citedOpen Access
Evidence for a loss of analgesia when hydromorphone is administered in combination with hange-shashin-to: Enterohepatic circulation and β-glucuronidase inhibition
International Journal of Clinical Pharmacology and Therapeutics·2025· 1 cited
Assessing the effects of interprofessional education by hospital pharmacists on pharmaceutical students using a self-evaluation scale
Journal of Pharmaceutical Health Care and Sciences·2024Open Access
Association between immune checkpoint inhibitor and cytomegalovirus infection: A pharmacovigilance study based on the adverse event reporting system
International Journal of Cancer·2024· 2 citedOpen Access
Implementing Medical SPD Supports Optimization of Ward-based Clinical Pharmacy Practices: An Interrupted Time-series Analysis
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)·2024· 2 citedOpen Access
Humoral immune response against SARS-CoV-2 and polyethylene glycol elicited by anti-SARS-CoV-2 mRNA vaccine, and effect of pre-existing anti-polyethylene glycol antibody in patients with hematological and autoimmune diseases
Heliyon·2024· 2 citedOpen Access
Treatment of Inflammatory Bowel Disease with Biologics in Japan: A Single-Center, Retrospective Pharmacoeconomic Study
Biological and Pharmaceutical Bulletin·2024Open Access
Humoral Immune Response Against SARS-CoV-2 and Polyethylene Glycol Elicited by Anti-SARS-CoV-2 mRNA Vaccine in Patients with Hematological and Autoimmune Disease
SSRN Electronic Journal·2024· 1 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Keisuke Ishizawa(31), Yoshito Zamami(22), Mitsuhiro Goda(20), Masayuki Chuma(18), Hirofumi Hamano(15), Takahiro Niimura(13), Kenta Yagi(12), Kenshi Takechi(11), Yuki Izawa‐Ishizawa(10), Kazuyoshi Kawazoe(10), Hiroaki Yanagawa(10), Momoyo Azuma(9), Toshimi Nakamura(8), Takumi Sakurada(7), Kazuhiko Teraoka(7), Fuka Aizawa(7), Masaki Imanishi(6), Masahiro Abe(6), Yoshiki Hirooka(5), Hidemi Goto(5)